Indication
Von Hippel-Lindau Syndrome
7 clinical trials
7 products
Clinical trial
An Open Label Phase 2 Study to Evaluate PT2385 for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell CarcinomaStatus: Completed, Estimated PCD: 2023-08-30
Product
PT2385Clinical trial
An Open-Label Phase 2 Study to Evaluate PT2977 for the Treatment of Von Hippel Lindau Disease-Associated Renal Cell CarcinomaStatus: Active (not recruiting), Estimated PCD: 2026-03-29
Product
BelzutifanClinical trial
A Phase II Trial of Pazopanib in Von Hippel-Lindau SyndromeStatus: Completed, Estimated PCD: 2024-03-13
Product
PazopanibClinical trial
Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma Based on Accurate Genotyping: a Population-based StudyStatus: Recruiting, Estimated PCD: 2025-06-30
Product
Single cell sequencingClinical trial
Pilot Study of Sunitinib Malate for Advanced Ocular Disease of Von Hippel-Lindau SyndromeStatus: Terminated, Estimated PCD: 2011-02-01
Product
SunitinibClinical trial
A Phase 2 Study of SU011248 (Sunitinib Malate) in Von Hippel-Lindau SyndromeStatus: Terminated, Estimated PCD: 2011-05-01
Product
SU011248Clinical trial
Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer SyndromesStatus: Recruiting, Estimated PCD: 2025-08-01
Product
Gene test